Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar Syndrome.
- DOI
- 10.1016/j.omtm.2018.07.008
- Published
- 2018 Sep 21
- Container
- Molecular therapy. Methods & clinical development
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omtm.2018.07.008,
title = {Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar Syndrome.},
author = {Greig JA and Nordin JML and Draper C and McMenamin D and Chroscinski EA and Bell P and Gray JT and Richman LK and Wilson JM},
year = {2018},
journal = {Molecular therapy. Methods \& clinical development},
doi = {10.1016/j.omtm.2018.07.008},
url = {https://doi.org/10.1016/j.omtm.2018.07.008}
}RIS
TY - JOUR TI - Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar Syndrome. AU - Greig JA AU - Nordin JML AU - Draper C AU - McMenamin D AU - Chroscinski EA AU - Bell P AU - Gray JT AU - Richman LK AU - Wilson JM PY - 2018 JO - Molecular therapy. Methods & clinical development DO - 10.1016/j.omtm.2018.07.008 UR - https://doi.org/10.1016/j.omtm.2018.07.008 ER -
APA
JA, G., JML, N., C, D., D, M., EA, C., P, B., JT, G., LK, R., & JM, W. (2018). Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar Syndrome.. Molecular therapy. Methods & clinical development. https://doi.org/10.1016/j.omtm.2018.07.008
Source records
- pubmed · retrieved 2026-09-27T12:45:34.560Z